Adelene Q. Perkins
2014
In 2014, Adelene Q. Perkins earned a total compensation of $1.6M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $369,525 |
|---|---|
| Option Awards | $687,779 |
| Salary | $568,500 |
| Other | $9,675 |
| Total | $1,635,479 |
Perkins received $687.8K in option awards, accounting for 42% of the total pay in 2014.
Perkins also received $369.5K in non-equity incentive plan, $568.5K in salary and $9.7K in other compensation.
Rankings
In 2014, Adelene Q. Perkins' compensation ranked 5,382nd out of 13,032 executives tracked by ExecPay. In other words, Perkins earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,382 out of 13,032 | 59th |
Division Manufacturing | 1,925 out of 4,966 | 61st |
Major group Chemicals And Allied Products | 648 out of 1,686 | 62nd |
Industry group Drugs | 499 out of 1,365 | 63rd |
Industry Pharmaceutical Preparations | 391 out of 1,043 | 63rd |
Source: SEC filing on April 25, 2016.
Perkins' colleagues
We found four more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2014.